Antleron
Biotechnology ResearchFlanders, Belgium11-50 Employees
Antleron is a biotechnology R&D company based in Heverlee, Flanders, Belgium, focusing on bespoke cell and gene therapy development, bioprocess modelling, wet lab R&D, and clinical and industrial translation. The company aims to accelerate and lower the cost of delivering cell and gene therapies by integrating scalable, closed, automated bioreactors with AI-driven digital twins, supporting activities from discovery through process development to CMC and manufacturing optimization. Its offerings include a smart scale-down approach that combines lab-scale, modular bioreactors with its digital twin platform to predict and refine clinical-scale bioprocesses, and a fixed-bed upstream bioreactor platform designed to improve quality, consistency, and scalability from laboratory work to patient-ready products. Antleron serves clients involved in advanced therapy medicinal product development, providing methods to streamline process development and manufacturing systems while enabling more efficient translation from research to clinical and industrial applications. Recent activity includes participation in industry conferences and collaboration announcements that reflect ongoing engagement with external partners in bioprocessing and in silico pharmaceutical spaces.